Status:
WITHDRAWN
Effect of WhatsApp Messenger on Uptake of CRC Screening Study
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
CRC
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
It is estimated that there are about 1.4 million patients with colorectal cancer (CRC) worldwide, with a rising trend in CRC incidence in many Asian Pacific countries1. In Hong Kong, colorectal cancer...
Detailed Description
Background It is estimated that there are about 1.4 million patients with colorectal cancer (CRC) worldwide, with a rising trend in CRC incidence in many Asian Pacific countries1. In Hong Kong, colore...
Eligibility Criteria
Inclusion
- Age between 50 - 70
- Asymptomatic
Exclusion
- Lack of access to WhatsApp messenger
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03337776
Start Date
February 1 2019
End Date
December 31 2019
Last Update
August 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong